Hepatitis A Treatment
Links shared publicly online about this topic
Completing your Hepatitis C Treatment
pegassist.com — “Hear actual hepatitis c patient stories, and see what doctors have to say about treating hepatitis c.” View full resource at pegassist.com
Most Recently Shared on July 29, 2009 at 4:20 pm By:
Fabio Gratton Health Executive and Health Social Media
Reminds me of this: http://tr.im/uBYt Right? RT @nicoleljohnson: Thinkwhatspossible.com- nice execution of sharing real patient stories
Genetic Discovery May Improve Hepatitis C Treatment
health.msn.com — “Genetic Discovery May Improve Hepatitis C Treatment” View full resource at health.msn.com
Most Recently Shared on August 17, 2009 at 2:47 pm By:
Genetic Discovery May Improve Hepatitis C Treatment http://bit.ly/LwIXi
Top Hepatitis C Treatments Equally Effective
health.msn.com — “Top Hepatitis C Treatments Equally Effective” View full resource at health.msn.com
Most Recently Shared on July 22, 2009 at 10:07 pm By:
Top Hepatitis C Treatments Equally Effective http://bit.ly/fxQnx
New Hepatitis C Treatment Shows Promise:
health.msn.com — “New Hepatitis C Treatment Shows Promise:” View full resource at health.msn.com
Most Recently Shared on December 3, 2009 at 10:45 pm By:
New Hepatitis C Treatment Shows Promise: http://bit.ly/5tEbCC
Boceprevir Ups Hepatitis C Treatment Success
webmd.com — “Late-stage clinical trials find that adding Merck's boceprevir to standard hepatitis C therapy increases the viral cure rate up to 75% -- efficacy similar to that of Vertex's telaprevir.” View full resource at webmd.com
Most Recently Shared on August 9, 2010 at 9:54 pm By:
webMD: Boceprevir Ups Hepatitis C Treatment Success http://bit.ly/a0UGbS Full http://bit.ly/auHx67
Bristol to buy Inhibitex for hepatitis C treatment
health.yahoo.net — “(Reuters) - Bristol-Myers Squibb Co has agreed to acquire Inhibitex Inc for about $2.5 billion to gain access to its promising hepatitis C treatment, the companies said on Saturday. At $26 per share, the deal is a huge 163 percent premium to Inhibitex's closing price of $9.87 on Friday.” View full resource at health.yahoo.net
Most Recently Shared on January 8, 2012 at 6:40 am By:
Bristol to buy Inhibitex for hepatitis C treatment http://t.co/ntPmBUw7
Bristol to buy Inhibitex for hepatitis C treatment | Reuters
reuters.com — “(Reuters) - Bristol-Myers Squibb Co has agreed to acquire Inhibitex Inc for about $2.5 billion to gain access to its promising hepatitis C treatment, the companies said on Saturday.At $26 per share, the” View full resource at reuters.com
Most Recently Shared on January 8, 2012 at 4:42 am By:
Bristol to buy Inhibitex for hepatitis C treatment: (Reuters) - Bristol-Myers Squibb Co has agreed... http://t.co/0ivxHpZR #health #news
Top Hepatitis C Treatments Equally Effective
news.healingwell.com — “Top Hepatitis C Treatments Equally Effective” View full resource at news.healingwell.com
Most Recently Shared on July 22, 2009 at 9:12 pm By:
Top Hepatitis C Treatments Equally Effective news http://bit.ly/3RZs6g #hepatitis
Genetic Discovery May Improve Hepatitis C Treatment
halifaxhealth.org — “Genetic Discovery May Improve Hepatitis C Treatment” View full resource at halifaxhealth.org
Most Recently Shared on August 17, 2009 at 5:21 pm By:
Halifax Health Healthcare System
Genetic Discovery May Improve Hepatitis C Treatment http://bit.ly/PdnkM
Adding Third Drug May Improve Hepatitis C Treatment:
health.msn.com — “Adding Third Drug May Improve Hepatitis C Treatment:” View full resource at health.msn.com
Most Recently Shared on August 9, 2010 at 1:42 pm By:
Adding Third Drug May Improve Hepatitis C Treatment: http://bit.ly/bdGAJA
Small Genetic Variant Can Predict Response To Hepatitis C Treatment
medicalnewstoday.com — “A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalised therapy for this difficult to treat disease, the annual conference of th” View full resource at medicalnewstoday.com
Most Recently Shared on June 14, 2010 at 2:06 pm By:
Small Genetic Variant Can Predict Response To Hepatitis C Treatment http://mnt.to/3DQd #healthnews
24-week hepatitis C treatment as effective as 48-week treatment —
news.unchealthcare.org — “A new study, conducted in part at UNC, finds that a 24-week triple medication treatment course for hepatitis C is just as effective as a 48-week regimen.” View full resource at news.unchealthcare.org
Most Recently Shared on September 15, 2011 at 11:38 am By:
24-week hepatitis C treatment as effective as 48-week treatment. http://t.co/grpfcLJm [Study published by @nejm. #UNC co-author]
Janssen Seeks European Marketing Authorization For Investigational Hepatitis C Treatment Telaprevir
medicalnewstoday.com — “Janssen-Cilag International NV announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for telaprevir, an investigational, oral, direct-actin” View full resource at medicalnewstoday.com
Most Recently Shared on December 20, 2010 at 2:05 pm By:
Janssen Seeks European Marketing Authorization For Investigational Hepatitis C Treatment Telaprevir http://mnt.to/3PhN #liver #hepatitis
Spotting Gene Variants May Boost Hepatitis C Treatment
crosspollinate.org — “Spotting Gene Variants May Boost Hepatitis C Treatment” View full resource at crosspollinate.org
Most Recently Shared on January 28, 2011 at 6:28 am By:
healthy_food Healthy Eating Advisor
Spotting Gene Variants May Boost Hepatitis C Treatment #food http://bit.ly/fc9dzw
HCV New Drug Research: Hepatitis C Treatment: current and future perspectives
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C Treatment: current and future perspectives” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on November 14, 2010 at 7:34 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Hepatitis C Treatment: current and future perspectives http://goo.gl/fb/WUT6U
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Fabio Gratton
Co-founder & Chief Innovation Officer of Ignite Health. Passionate about Health, Digital, and Social Media.
-
msn
-
msn
Advertisement
